These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33550493)

  • 1. Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.
    Wyse ATS; Dos Santos TM; Seminotti B; Leipnitz G
    Mol Neurobiol; 2021 Jun; 58(6):2897-2909. PubMed ID: 33550493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah
    Dobrowolski SF; Sudano C; Phua YL; Tourkova IL; Spridik K; Goetzman ES; Vockley J; Blair HC
    Mol Genet Metab; 2021 Mar; 132(3):173-179. PubMed ID: 33602601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain bioenergetics in rats with acute hyperphenylalaninemia.
    Dimer NW; Ferreira BK; Agostini JF; Gomes ML; Kist LW; Malgarin F; Carvalho-Silva M; Gomes LM; Rebelo J; Frederico MJS; Silva FRMB; Rico EP; Bogo MR; Streck EL; Ferreira GC; Schuck PF
    Neurochem Int; 2018 Jul; 117():188-203. PubMed ID: 29454001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New View of Bone Loss in Phenylketonuria.
    Dobrowolski SF; Tourkova IL; Sudano CR; Larrouture QC; Blair HC
    Organogenesis; 2021 Oct; 17(3-4):50-55. PubMed ID: 34432558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bone mineralization defect in the Pah
    Dobrowolski SF; Tourkova IL; Robinson LJ; Secunda C; Spridik K; Blair HC
    Mol Genet Metab; 2018 Nov; 125(3):193-199. PubMed ID: 30201326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.
    Schuck PF; Malgarin F; Cararo JH; Cardoso F; Streck EL; Ferreira GC
    Aging Dis; 2015 Sep; 6(5):390-9. PubMed ID: 26425393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia.
    Item CB; Farhadi S; Schanzer A; Greber-Platzer S
    Clin Biochem; 2017 Aug; 50(12):729-732. PubMed ID: 28389235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia.
    Stojiljkovic M; Klaassen K; Djordjevic M; Sarajlija A; Kecman B; Ugrin M; Zukic B; Desviat LR; Pavlovic S; Perez B
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):477-80. PubMed ID: 25418970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia.
    Güttler F; Guldberg P
    Acta Paediatr Suppl; 1994 Dec; 407():49-56. PubMed ID: 7766959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia.
    Sarkissian CN; Scriver CR; Mamer OA
    Anal Biochem; 2000 May; 280(2):242-9. PubMed ID: 10790306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-13C]phenylalanine oxidation rates in vivo: a pilot study.
    Treacy EP; Delente JJ; Elkas G; Carter K; Lambert M; Waters PJ; Scriver CR
    Pediatr Res; 1997 Oct; 42(4):430-5. PubMed ID: 9380432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine.
    Loo YH; Scotto J; Wisniewski HM
    Adv Exp Med Biol; 1978; 100():453-69. PubMed ID: 151497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine nanoliposome reverts the HPA-induced damage in complex II-III activity of the rats' cerebral cortex.
    Mezzomo NJ; Becker Borin D; Ianiski F; Dotto Fontana B; Diehl de Franceschi I; Bolzan J; Garcez R; Grings M; Parmeggiani B; da Silva Fernandes L; de Almeida Vaucher R; Leipnitz G; Duval Wannmacher CM; Cielo Rech V
    Mol Biol Rep; 2019 Dec; 46(6):5897-5908. PubMed ID: 31410688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Okano Y; Hase Y; Kawajiri M; Nishi Y; Inui K; Sakai N; Tanaka Y; Takatori K; Kajiwara M; Yamano T
    Pediatr Res; 2004 Nov; 56(5):714-9. PubMed ID: 15319459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, genetic, and experimental research of hyperphenylalaninemia.
    Chen A; Pan Y; Chen J
    Front Genet; 2022; 13():1051153. PubMed ID: 36685931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector.
    Cerreto M; Mehdawy B; Ombrone D; Nisticò R; Ruoppolo M; Usiello A; Daniele A; Pastore L; Salvatore F
    Curr Gene Ther; 2012 Feb; 12(1):48-56. PubMed ID: 22348550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.